| AMEFX | FASGX | AMEFX / FASGX | |
| Total Expense Ratio | 0.37 | 0.63 | 59% |
| Annual Report Gross Expense Ratio | 0.37 | 0.66 | 56% |
| Fund Existence | 18 years | 35 years | - |
| Gain YTD | 8.815 | 11.632 | 76% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 150B | 8.89B | 1,688% |
| Annual Yield % from dividends | 3.55 | 1.64 | 217% |
| Returns for 1 year | 5.18 | 9.95 | 52% |
| Returns for 3 years | 39.42 | 44.07 | 89% |
| Returns for 5 years | 26.11 | 25.61 | 102% |
| Returns for 10 years | 62.25 | 92.19 | 68% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CDVZX | 21.51 | 0.15 | +0.70% |
| Columbia Intrinsic Value Institutional | |||
| FFOTX | 54.76 | N/A | N/A |
| Fidelity Advisor Technology - Z | |||
| FRBRX | 213.20 | N/A | N/A |
| Franklin Biotechnology Discovery R6 | |||
| BIREX | 16.30 | N/A | N/A |
| BlackRock Real Estate Securities Instl | |||
| EFEAX | 11.88 | N/A | N/A |
| Ashmore Emerging Mkts Frontier Eq A | |||